Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 40.71 | 36.80 | 57.02 | 53.54 | 59.39 | 62.83 | 72.80 | 60.02 | 72.72 | 71.47 | 72.41 | 82.17 |
| Expenses | 37.14 | 33.34 | 48.88 | 48.91 | 52.99 | 57.30 | 66.28 | 56.86 | 66.65 | 69.64 | 72.19 | 77.09 |
| Operating Profit | 3.57 | 3.46 | 8.14 | 4.63 | 6.40 | 5.53 | 6.52 | 3.16 | 6.07 | 1.83 | 0.22 | 5.08 |
| OPM % | 8.77% | 9.40% | 14.28% | 8.65% | 10.78% | 8.80% | 8.96% | 5.26% | 8.35% | 2.56% | 0.30% | 6.18% |
| Other Income | 1.16 | 0.29 | 0.46 | 0.32 | 0.97 | 0.45 | 0.19 | 0.98 | 0.66 | 0.93 | 2.08 | 0.94 |
| Interest | 0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.02 | 0.01 |
| Depreciation | 0.23 | 0.27 | 0.28 | 0.37 | 0.28 | 0.50 | 0.56 | 0.27 | 0.34 | 0.56 | 0.61 | 0.70 |
| Profit before tax | 4.48 | 3.47 | 8.31 | 4.58 | 7.09 | 5.48 | 6.15 | 3.87 | 6.39 | 2.10 | 1.67 | 5.31 |
| Tax % | 16.74% | 29.39% | 23.59% | 25.55% | 24.40% | 27.19% | 29.76% | 25.84% | 21.91% | 25.71% | 19.16% | 20.90% |
| Net Profit | 3.73 | 2.45 | 6.35 | 3.42 | 5.37 | 3.99 | 4.32 | 2.87 | 4.99 | 1.56 | 1.36 | 4.19 |
| EPS in Rs | 2.33 | 1.53 | 3.96 | 2.14 | 3.35 | 2.40 | 2.60 | 1.73 | 2.88 | 0.90 | 0.78 | 2.42 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 40 | 77 | 123 | 170 | 241 | 274 | 299 |
| Expenses | 30 | 40 | 71 | 113 | 151 | 218 | 263 | 286 |
| Operating Profit | 0 | 0 | 6 | 10 | 19 | 23 | 11 | 13 |
| OPM % | 0.8% | 1.2% | 7% | 8% | 11% | 10% | 4.2% | 4.4% |
| Other Income | 0 | 0 | 0 | 0 | 1 | 2 | 5 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 0 | 0 | 5 | 10 | 19 | 23 | 14 | 15 |
| Tax % | 0% | 27% | 0% | 24% | 22% | 27% | 23% | |
| Net Profit | 0 | 0 | 5 | 8 | 15 | 17 | 11 | 12 |
| EPS in Rs | 4.50 | 16.50 | 250.00 | 5.92 | 9.42 | 10.28 | 6.22 | 6.98 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 47% | 31% | 17% | ||
| Compounded Profit Growth | % | 87% | 0% | -27% | ||
| Stock Price CAGR | % | % | 1% | -30% | ||
| Return on Equity | % | 16% | 13% | 5% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 0.20 | 13 | 16 | 17 | 17 |
| Reserves | 0 | 0 | 6 | 3 | 52 | 116 | 157 |
| Borrowings | 1 | 2 | 3 | 1 | 0 | 0 | 0 |
| Other Liabilities | 4 | 4 | 10 | 11 | 17 | 17 | 21 |
| Total Liabilities | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
| Fixed Assets | 0 | 0 | 1 | 2 | 2 | 15 | 22 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 5 | 1 |
| Investments | 0 | 0 | 0 | 0 | 12 | 44 | 45 |
| Other Assets | 4 | 6 | 18 | 26 | 70 | 86 | 128 |
| Total Assets | 5 | 7 | 19 | 28 | 86 | 150 | 196 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 1 | -0 | 0 | 2 | -11 | -5 | -27 |
| Cash from Investing Activity | -0 | -1 | -0 | -1 | -22 | -42 | -4 |
| Cash from Financing Activity | -0 | 1 | 1 | -0 | 36 | 47 | 30 |
| Net Cash Flow | 0 | -0 | 1 | 1 | 3 | 0 | -1 |
| Free Cash Flow | 0 | -1 | -0 | -0 | -14 | -23 | -31 |
| CFO/OP | 348% | -84% | 9% | 40% | -35% | 6% | -201% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 10 | 7 | 6 | 3 | 24 | 21 | 15 |
| Inventory Days | 34 | 30 | 63 | 70 | 99 | 112 | 150 |
| Days Payable | 44 | 30 | 32 | 28 | 33 | 23 | 26 |
| Cash Conversion Cycle | 0 | 6 | 37 | 45 | 90 | 110 | 139 |
| Working Capital Days | -5 | -8 | 19 | 36 | 84 | 95 | 134 |
| ROCE % | 29% | 95% | 80% | 45% | 22% | 8% |
| Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.62% | 69.62% | 69.62% | 69.62% | 69.62% | 69.30% | 66.50% | 65.97% | 66.00% | 60.75% | 60.19% | 60.19% |
| FIIs | 2.61% | 0.00% | 0.00% | 0.00% | 0.02% | 0.22% | 3.54% | 3.53% | 4.00% | 7.50% | 6.93% | 6.93% |
| DIIs | 2.25% | 1.69% | 0.65% | 0.64% | 0.23% | 1.28% | 1.72% | 1.77% | 1.00% | 0.87% | 1.66% | 2.19% |
| Public | 25.53% | 28.69% | 29.73% | 29.74% | 30.13% | 29.20% | 28.24% | 28.73% | 30.00% | 30.88% | 31.23% | 30.70% |
| No. of Shareholders | 738 | 1,000 | 1,807 | 2,065 | 2,508 | 2,798 | 2,988 | 3,113 | 3,054 | 2,946 | 2,495 | 2,597 |
Fundamentals
Market Cap₹ 754 Cr.
Current Price₹ 435
Stock P/E62.3
Book Value₹ 101
ROCE7.54 %
ROE4.88 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)17%
Compounded Profit Growth (TTM)-27%
Standalone figures.
Valuation
Market capRs 589 Cr
Enterprise valueRs 589 Cr
P/E (TTM)48.72x
Price to book37.24x
Price to sales1.97x
EV / EBITDA32.58x
EV / EBIT37.11x
EV / sales1.97x
Price to cash flow338.77x
Earnings yield2.05%
Profitability
Operating margin (excl. other income)8.45%
Operating margin (incl. other income)8.84%
EBITDA margin6.05%
Pre-tax margin5.18%
Net profit margin4.05%
Net margin, latest quarter5.10%
ROE70.50%
ROCE80.11%
ROA32.42%
ROE, 3-year average101.45%
ROCE, 3-year average68.16%
ROA, 3-year average25.47%
ROIC (approx.)78.87%
Tax rate23.62%
Other income / net worth3.03%
Growth
Sales growth (latest year)60.17%
Profit growth (latest year)52.00%
Sales CAGR, 3 years59.40%
Profit CAGR, 3 years338.72%
Sales growth QoQ13.48%
Profit growth QoQ208.09%
Sales growth YoY (latest quarter)36.90%
Profit growth YoY (latest quarter)45.99%
Per share
EPS (TTM)Rs 9.42
EPS (latest year)Rs 5.92
EPS (latest quarter)Rs 3.26
EPS, 3-year averageRs 90.81
Book value per shareRs 12.33
Sales per shareRs 232.65
Cash flow per shareRs 1.35
Free cash flow per shareRs -24.14
Efficiency
Asset turnover4.44x
Fixed asset turnover60.99x
Inventory turnover5.52x
Inventory days66 days
Debtor days3 days
Debtors turnover125.71x
Creditor days26 days
Cash conversion cycle139 days
Working capital days134 days
Leverage
Total debtRs 1 Cr
Cash and bankRs 1 Cr
Net debtRs -0 Cr
Debt to equity0.06x
Net debt / EBITDA-0.03x
Interest coverage39.67x
Owners' fund to total sources57.07%
Debt to assets3.68%
Cash flow
Cash from Operating Activity (latest year)Rs 2 Cr
Cash from Investing Activity (latest year)Rs -1 Cr
Cash from Financing Activity (latest year)Rs -0 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -31 Cr
FCFE (approx.: FCF + change in debt)Rs -33 Cr
Cash from ops / profit, 5 years-0.73x
Sales to cash flow70.80x
Statement figures
Net sales (TTM)Rs 299 Cr
Net sales (latest year)Rs 123 Cr
Sales (latest quarter)Rs 82 Cr
Operating profit excl. other income (latest year)Rs 10 Cr
Operating profit (latest quarter)Rs 5 Cr
Other income (TTM)Rs 5 Cr
EBITDA (TTM)Rs 18 Cr
PBDT (TTM)Rs 18 Cr
Profit before tax (TTM)Rs 15 Cr
Tax (latest year)Rs 2 Cr
Net profit (TTM)Rs 12 Cr
Net profit (latest year)Rs 8 Cr
Net profit (latest quarter)Rs 4 Cr
Depreciation (TTM)Rs 2 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 98 Cr
Total expenditure (latest year)Rs 113 Cr
Total income (latest year)Rs 124 Cr
Share capitalRs 13 Cr
ReservesRs 3 Cr
Shareholders' fundsRs 16 Cr
Total assetsRs 28 Cr
Net blockRs 2 Cr
ReceivablesRs 1 Cr
InventoryRs 18 Cr
Other liabilitiesRs 11 Cr
Shares outstanding (crore)1.28
Ownership
Promoter holding60.19% (-5.78 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | DENTALKART | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +11.1% | -2.8% | +13.9 pts |
| 1 month | +15.4% | -6.8% | +22.2 pts |
| 3 months | +22.4% | -7.6% | +30.0 pts |
| 6 months | +36.3% | +0.4% | +35.9 pts |
| 1 year | -25.7% | -9.9% | -15.8 pts |
| 2 years | -19.9% | -13.6% | -6.4 pts |
| 3 years | +7.9% | +14.2% | -6.2 pts |
1 mutual fund schemes hold about ₹2 Cr.
Over three months 0 bought more and 0 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| WOC ELSS Tax Saver Fund | 0.41% | 2 |
Red flags
F-score 6 of 8| explain | Weak cash conversion Cash from operations was 12% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 21% of total assets in 2026 |
| explain | Share dilution Share count up 6300% in a year, 6300% in three |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹82 Cr +36.9% vs Jun 2025.
Net profit ₹4 Cr +46.0%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Poly Medicure Ltd | 16,671 | 52.1 | 12.5 % |
| Molbio Diagnostics Ltd | 14,470 | 66.6 | 18.0 % |
| Fischer Medical Ventures Ltd | 2,355 | 96.2 | 11.4 % |
| Tarsons Products Ltd | 1,754 | 148 | 4.59 % |
| Q-Line Biotech Ltd | 1,569 | 27.8 | 22.5 % |
| Laxmi Dental Ltd | 1,058 | 30.4 | 15.0 % |
| Hemant Surgical Industries Ltd | 869 | 51.3 | 18.9 % |
| OSEL Devices Ltd | 691 | 23.6 | 24.4 % |
| Prevest Denpro Ltd | 462 | 20.5 | 24.9 % |
| QMS Medical Allied Services Ltd | 419 | 39.0 | 12.9 % |
| Nureca Ltd | 349 | 80.4 | 3.30 % |
| Aprameya Engineering Ltd | 200 | 39.7 | 12.6 % |
| Avience Biomedicals Ltd | 198 | 22.7 | 27.0 % |
| Earkart Limited | 179 | 36.3 | 17.5 % |
| Vaidya Sane Ayurved Laboratories Ltd | 176 | 19.6 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysMandatory Market making period in SME scrip is overSME scrip is not regularly tradedScrip PE is greater than 50 (4 trailing quarters)
Quick answers
What is the market cap of Vasa Denticity Ltd?
Vasa Denticity Ltd (DENTALKART) has a market capitalisation of Rs 754 Cr. at the 2026-10-01 close.
What is the P/E ratio of Vasa Denticity Ltd?
Vasa Denticity Ltd trades at a P/E of 62.3 on trailing twelve-month profit, at the 2026-10-01 close.
What were Vasa Denticity Ltd's latest quarterly results?
In the Jun 2026 quarter, Vasa Denticity Ltd sales was Rs 82 Cr (+36.9% vs Jun 2025) and net profit was Rs 4 Cr.
What is the 52-week high and low of Vasa Denticity Ltd?
The 52-week high is Rs 622.00 and the 52-week low is Rs 322.50.